EBV潜伏膜蛋白2A通过Cks1介导p27kip1降解加速小鼠MYC驱动淋巴瘤
该研究在转基因小鼠模型中探讨EBV潜伏膜蛋白2A(LMP2A)加速MYC驱动淋巴瘤的机制。研究发现LMP2A通过增强MYC表达及MYC依赖的p27kip1降解促进B细胞过度增殖,而Cks1缺失可增加p27kip1表达、降低脾重、恢复B细胞滤泡形成、阻碍肿瘤前B细胞周期进展并延长肿瘤发生时间。
要点
- LMP2A通过增强MYC表达和MYC依赖的p27kip1降解促进B细胞过度增殖。
- Cks1缺失在肿瘤前阶段增加p27kip1表达。
- 在表达LMP2A的小鼠中,Cks1缺失降低脾重、恢复B细胞滤泡形成、阻碍肿瘤前B细胞周期进展并延长MYC驱动肿瘤发生时间。
核心结论
- LMP2A利用MYC在细胞周期中的作用,特别是p27kip1降解过程,在体内加速淋巴瘤发生。
- 结果揭示了EBV改变MYC在恶性转化中功能的新机制,并为靶向EBV在细胞周期调控中的作用提供了依据。
研究设计与样本
- 研究采用转基因小鼠模型,研究LMP2A在体内淋巴瘤发生中的作用。
主要发现
- LMP2A通过增强MYC表达和MYC依赖的p27kip1降解促进B细胞过度增殖。
- Cks1缺失在肿瘤前阶段增加p27kip1表达。
- 在表达LMP2A的小鼠中,Cks1缺失降低脾重、恢复B细胞滤泡形成、阻碍肿瘤前B细胞周期进展,并最终延长MYC驱动肿瘤发生时间。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Epstein-Barr virus (EBV) establishes lifelong infection in B lymphocytes of most human hosts and is associated with several B lymphomas. During latent infection, EBV encodes latent membrane protein 2A (LMP2A) to promote the survival of B cells by mimicking host B-cell receptor signaling. By studying the roles of LMP2A during lymphoma development in vivo, we found that LMP2A mediates rapid MYC-driven lymphoma onset by allowing B cells to bypass MYC-induced apoptosis mediated by the p53 pathway in our transgenic mouse model. However, the mechanisms used by LMP2A to facilitate transformation remain elusive. In this study, we demonstrate a key role of LMP2A in promoting hyperproliferation of B cells by enhancing MYC expression and MYC-dependent degradation of the p27kip1 tumor suppressor. Loss of the adaptor protein cyclin-dependent kinase regulatory subunit 1 (Cks1), a cofactor of the SCFSkp2 ubiquitin ligase complex and a downstream target of MYC, increases p27kip1 expression during a premalignant stage. In mice that express LMP2A, Cks1 deficiency reduces spleen weights, restores B-cell follicle formation, impedes cell cycle progression of pretumor B cells, and eventually prolongs MYC-driven tumor onset. This study demonstrates that LMP2A uses the role of MYC in the cell cycle, particularly in the p27kip1 degradation process, to accelerate lymphomagenesis in vivo. Thus, our results reveal a novel mechanism of EBV in diverting the functions of MYC in malignant transformation and provide a rationale for targeting EBV's roles in cell cycle modulation.
引用
- Fish K, Sora RP, Schaller SJ, et al. EBV latent membrane protein 2A orchestrates p27kip1 degradation via Cks1 to accelerate MYC-driven lymphoma in mice. Blood. 2017. PMID: 29074502. doi:10.1182/blood-2017-07-796821
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。